: £72.1 million, a 22.1% increase compared to H1 2024 (£59.0 million). Gross Profit : £61.4 million, up 24% year-on-year.
: A refined commercial strategy identified high-priority opportunities in applied and research markets worth an estimated $13 to $14 billion . : £72
: Completed a programme resulting in an approximately 5% reduction in workforce to reallocate capital to growth areas. : £72.1 million
: £13.0 million (+52.9%), driven by AMR and EMEAI growth. : £72
The full text and detailed report of this "paper" (regulatory announcement) include the following key sections and financial highlights: